Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 10, 2018
Patent Application Number
15374272
Date Filed
December 9, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to chimeric chemical compounds which are used to recruit antibodies to cancer cells, in particular, prostate cancer cells or metastasized prostate cancer cells. The compounds according to the present invention comprise an antibody binding terminus (ABT) moiety covalently bonded to a cell binding terminus (CBT) and Toll-like receptor agonist (TLR) through a linker and a multifunctional connector group or molecule.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
